VP, Investor Relations

Company Overview

Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is a novel, point‑of‑care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting, and is being used in hundreds of community hospitals, large academic facilities and major IDNs across the country.

Our entire team is driven by a shared commitment to transforming the landscape of critical care through our rapid seizure detection technology.

• Develop and execute a best‑in‑class investor relations strategy aligned with corporate objectives.
• Serve as a spokesperson to investors, analysts, and the broader financial community.
• Advise executive leadership on market perception, valuation drivers, and investor sentiment.
• Partner with internal stakeholders to ensure consistent, compliant, and high‑impact disclosures.
• Craft and continuously refine a compelling equity story that balances near‑term commercial execution with long‑term value creation.
• Translate complex Med Tech/scientific concepts into clear, credible, and differentiated messaging for investors.
• Work with executive management to refine and improve message delivery.
• Develop high‑impact content including investor presentations, earnings scripts, shareholder letters, and press releases.
• Plan and coordinate all investor‑facing activities including quarterly earnings calls, investor conferences, roadshows, analyst days, and investor events.
• Anticipate investor questions and prepare high‑impact responses.
• Build and maintain strong relationships with institutional investors, sell‑side analysts, and key stakeholders.
• Develop and execute investor targeting strategies to attract long‑term, high‑quality shareholders.
• Monitor Med Tech, healthcare, and financial market news flow and trends.
• Lead high‑impact strategic, business‑development, or financial initiatives outside of core IR responsibilities.

• 10+ years of experience in Investor Relations or a related field (e.g., Equity Research), with direct experience in Investor Relations strongly preferred.
• Commercial‑stage Medical Technology experience required (devices, diagnostics, or closely aligned healthcare sector).
• Demonstrated ability to build and communicate a compelling investor narrative in complex, science‑driven industries.
• Poise and executive presence in communicating with internal and external stakeholders.
• Proven experience in a public company environment with strong knowledge of SEC/ disclosure requirements.
• Strong relationships within the healthcare investment community.
• Ability to understand and confidently communicate medical technology terms of art including clinical, regulatory, and reimbursement concepts.
• Bachelor’s degree required; advanced degree preferred.

Salary range: $280,000 – $325,000 USD. Compensation may include bonuses consistent with Ceribell’s corporate compensation plan and equity opportunities.

• Annual bonus and equity opportunity
• 100% employer‑paid health benefits for employees
• 100% paid life and long‑term disability insurance
• 401(k) with a generous company match
• Employee Stock Purchase Plan (ESPP) with a discount
• Monthly cell phone stipend
• Flexible paid time off
• 13 paid holidays plus 3 company wellness days
• Excellent parental leave policy
• Fantastic culture with tremendous career advancement opportunities
• Joining a mission‑minded organization

All qualified applicants will receive consideration for employment without regard to race, color, religion, sex (including pregnancy, childbirth and related medical conditions), sexual orientation, gender identity or expression, national origin, age, marital status, disability, veteran status or any other characteristic protected by law. Any applicant with a disability who requires an accommodation during the application process should contact  to request reasonable accommodation.